The combined application of nucleotide and amino acid sequences of NS3 hepatitis C virus protein, DNA encoding granulocyte macrophage colony-stimulating factor, and inhibitor of regulatory T cells induces effective immune responce against Hepatitis C virus
Masalova O.V.,RAS D. I. Ivanovsky Institute of Virology |
Lesnova E.I.,RAS D. I. Ivanovsky Institute of Virology |
Shingarova L.N.,RAS Shemyakin Ovchinnikov Institute of Bioorganic Chemistry |
Tunitskaya V.L.,RAS Engelhardt Institute of Molecular Biology |
And 3 more authors.
Molecular Biology | Year: 2012
Hepatitis C is related to the most important socially significant human infectious diseases. However, there is no vaccine for the hepatitis C virus. The nonstructural protein NS3 of the hepatitis C virus (HCV), which is synthesyzed in the infected cells and it displays protease, NTPase, and helicase enzymatic activities, is one of the possible components of the vaccine. The connection between the effectiveness of the T-cell response to NS3 epitopes and the spontaneous resolution of acute hepatitis C has been shown. The purpose of this work was to compare the immune response of mice to the inoculation of the nucleotide and amino acid sequences of HCV NS3 and their combination, as well as to evaluate the adjuvant activity of the DNA encoding of granulocyte macrophage colony-stimulating factor (GM-CSF) and the influence of regulatory T cells on the effectiveness of the immune response. The maximum anti-HCV NS3 antibody level in the serum (up to 1: 640000) induced the recombinant rNS3 protein introduced with aluminum hydroxide. The most intensive cellular immune response was observed after the simultaneous administration of rNS3 and DNAs encoding full-size NS3 and GM-CSF. A high level of lymphocyte proliferation, accumulation of IFN-γ-secreting cells, and IFN-γ/IL-2 release in response to the stimulators (NS3 antigens of different compositions) were observed in this group of mice. It has been established that the in vitro suppression of regulatory T cells leads to a statistically significant increase in the secretion of IFN-γ. Thus, the simultaneous application of rNS3, along with the DNAs encoding full-size NS3 and GM-CSF, is a promising approach to the development of hepatitis C vaccine. The expediency of adding regulatory T-cell inhibitors in the vaccine composition will be clear after special studies. © 2012 Pleiades Publishing, Ltd.
Masalova O.V.,Russian Academy of Medical Sciences |
Lesnova E.I.,Russian Academy of Medical Sciences |
Grabovetskii V.V.,Russian Academy of Medical Sciences |
Smirnova O.A.,RAS Engelhardt Institute of Molecular Biology |
And 6 more authors.
Molecular Biology | Year: 2010
In spite of extensive research, no effective vaccine against hepatitis C virus (HCV) has been developed so far. DNA immunization is a potent technique of vaccine design strongly promoting the cellular arm of immune response. The genes encoding nonstructural HCV proteins (NS2-NS5B) are promising candidates for vaccine development. NS5A is a protein involved in viral pathogenesis, in the induction of immune response, and probably in viral resistance to interferon treatment. The objective of this study was to construct a DNA vaccine encoding NS5A protein and evaluate its immunogenicity. A plasmid encoding a full-size NS5A protein was produced using the pcDNA3. 1 (+) vector for eukaryotic expression system. The expression of the NS5A gene was confirmed by immunoperoxidase staining of the transfected eukaryotic cells with anti- NS5A monoclonal antibodies. Triple immunization of mice with the plasmid vaccine induced a pronounced cellular immune response against a broad spectrum of NS5A epitopes as assessed by T-cell proliferation and secretion of antiviral cytokines IFN-γ and IL-2. In T-cell stimulation in vitro experiments, NS5A-derived antigens were modeled by synthetic peptides, recombinant proteins of various genotypes, and phages carrying exposed NS5A peptides. A novel immunomodulator Immunomax showed high adjuvant activity in DNA immunization. The data obtained indicate that the suggested DNA construct has a strong potential in the development of the gene vaccines against hepatitis C. © Pleiades Publishing, Inc., 2010.